We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Tecan, CellSpring Collaborate

Read time: Less than a minute

Tecan and CellSpring have announced a co-marketing agreement to automate the 3D Bloom® platform on a Freedom EVO® workstation. This latest collaboration will further extend Tecan’s automated 3D cell culture portfolio, allowing scientists to take advantage of a high throughput technology with an extended cell viability period of at least seven days in the assay matrix.

The adaptive 3D Bloom Biopolymer Platform is compatible with all cell types and is ideal for both mono and co-culture assays. 3D micro tissues can be prepared in microplate format within minutes, and analysis carried out while still in the culture matrix.

Kevin Moore, Manager of Liquid Handling Products and Application Management, commented: “As a leader in the field of automated 3D cell culture, Tecan is delighted to be working with CellSpring to implement its microplate-based 3D Bloom platform on the Freedom EVO. This will allow scientists to benefit from straightforward, high throughput automation of a 3D cell culture process offering long-term cell viability.”
 
Dr Chris Millan, Chief Technology Officer at CellSpring, added: “CellSpring is excited to partner with Tecan to bring automated, simple 3D cell culture solutions to customers. The benefits of our 3D Bloom Platform – versatility and reliability – are now available at scale using the Freedom EVO.”

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.